BETTERLIFE PHARMA INC.: 10-Q filed 2018-09-14
What BETTERLIFE PHARMA INC. reported in its quarterly report filed 2018-09-14 (fiscal Q2 2019): 24 published measures, 56 facts as tagged in accession 0001477932-18-004502.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2018-09-14
- Fiscal period
- fiscal Q2 2019
- Accession
- 0001477932-18-004502 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BETTERLIFE PHARMA INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | 7,587,216 | USD | |
| At 2018-01-31 | 383,817 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | 4,286,615 | USD | |
| At 2018-01-31 | 429,200 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | 3,300,601 | USD | |
| At 2018-01-31 | -45,383 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | 474,491 | USD | |
| At 2018-01-31 | 64,511 | USD | |
| At 2017-07-31 | 9,943 | USD | |
| At 2017-01-31 | 112,421 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-05-01 to 2018-07-31 | -1,414,447 | USD | 92 |
| 2018-02-01 to 2018-07-31 | -3,038,841 | USD | 181 |
| 2017-05-01 to 2017-07-31 | -5,556 | USD | 92 |
| 2017-02-01 to 2017-07-31 | -325,368 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-07-31 | -2,854,479 | USD | 181 |
| 2017-02-01 to 2017-07-31 | -103,522 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-07-31 | 3,584,740 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-07-31 | -333,333 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | -23,757,776 | USD | |
| At 2018-01-31 | -20,718,935 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | 3,641 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-05-01 to 2018-07-31 | -1,181,063 | USD | 92 |
| 2018-02-01 to 2018-07-31 | -2,627,521 | USD | 181 |
| 2017-05-01 to 2017-07-31 | -248,755 | USD | 92 |
| 2017-02-01 to 2017-07-31 | -534,273 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | 676,865 | USD | |
| At 2018-01-31 | 149,253 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-05-01 to 2018-07-31 | 96,962 | USD | 92 |
| 2018-02-01 to 2018-07-31 | 164,627 | USD | 181 |
| 2017-05-01 to 2017-07-31 | 8,365 | USD | 92 |
| 2017-02-01 to 2017-07-31 | 17,154 | USD | 181 |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | 6,714,660 | USD | |
| At 2018-01-31 | 234,564 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-05-01 to 2018-07-31 | 1,181,063 | USD | 92 |
| 2018-02-01 to 2018-07-31 | 2,627,521 | USD | 181 |
| 2017-05-01 to 2017-07-31 | 248,755 | USD | 92 |
| 2017-02-01 to 2017-07-31 | 534,273 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-05-01 to 2018-07-31 | 86,781 | USD | 92 |
| 2018-02-01 to 2018-07-31 | 172,074 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | 88,496,603 | shares | |
| At 2018-01-31 | 82,373,559 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | 12,068,876 | USD | |
| At 2018-01-31 | 11,816,057 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | 574,236 | USD | |
| At 2018-01-31 | 593,728 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-07-31 | 5,700 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-05-01 to 2018-07-31 | -1,427,976 | USD | 92 |
| 2018-02-01 to 2018-07-31 | -3,058,333 | USD | 181 |
| 2017-05-01 to 2017-07-31 | -3,475 | USD | 92 |
| 2017-02-01 to 2017-07-31 | -262,895 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-05-01 to 2018-07-31 | 427,753 | USD | 92 |
| 2018-02-01 to 2018-07-31 | 1,177,168 | USD | 181 |
| 2017-05-01 to 2017-07-31 | 75,641 | USD | 92 |
| 2017-02-01 to 2017-07-31 | 128,930 | USD | 181 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-07-31 | 315,827 | USD | 181 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-02-01 to 2018-07-31 | 128,226 | USD | 181 |
Inspect the source
- Entity
- BETTERLIFE PHARMA INC. / CIK 0001464165
- Captured
- 2026-09-20T09:06:34.124Z
- SEC response SHA-256
da89258f023cbc29ad1ecdd31014873fa96a7739fba3e7b66a8b80f8715d36cf
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001464165.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))